UTime shares surge 30.39% after-hour after securing $10M smart health devices deal with Tumu Vertex.

UTime Limited (NASDAQ: WTO) surged 30.39% in after-hours trading following the announcement of a $10 million procurement agreement with Denver-based Tumu Vertex LLC for 50,000 smart health devices, including blood pressure watches and ECG rings. The deal, marking UTime’s entry into the North American medical-grade wearable market, features FOB Hong Kong delivery and joint quality control, with first shipments in Q1 2026. The company emphasized the strategic importance of the partnership, highlighting FDA-certified technology integration and market recognition of its capabilities. Tumu Vertex’s CEO praised UTime’s innovation, positioning the collaboration to expand its U.S. health service platform. The agreement aligns with growing demand for health monitoring solutions and underscores UTime’s expansion into medical technology.